ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1168

MiR125a-5p Mediates Angiogenic Mechanisms in Inflammatory Arthritis

Mary Connolly1, Sarah Wade1, Douglas J. Veale2 and Ursula Fearon1, 1St. Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland, 2St Vincent's University Hospital, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, Dublin 4, Ireland

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Cytokines and fibroblasts, MicroRNA

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: MicroRNAs (miRNA) belong to a class of small, evolutionarily conserved, noncoding RNAs that function as post-transcriptional repressors of gene expression. An accumulating body of evidence suggests that up to 50% of the human genome is regulated by miRNAs.  The aim of this study was to examine expression, regulation and function of miRNA-125a-5p in inflammatory arthritis (IA).

Methods:  Synovial tissue biopsies and primary synovial fibroblasts (SFC) were obtained from patients with Psoriatic arthritis (PsA), Rheumatoid Arthritis (RA) and osteoarthritis (OA). MiR125a-5p levels were analyzed by real-time PCR and data was calculated by the deltaCt method using RNU6B as an endogenous control. To examine possible factors involved in regulating miR125a-5p expression, primary synovial fibroblasts (SFC) and microvascular endothelial cells (HMVEC) were cultured with candidate pro-inflammatory stimuli including; TLR ligands (PAM, PolyIC, LPS), pro-inflammatory cytokines (TNFa, IL-1b, IL-17) and growth factors (VEGF, Ang2). Overexpression/silencing of miR-125a-5p was analysed using a synthetic precursor of Pre or Anti-miR™-125, respectively. Cell invasion, tube formation and migration were examined using transwell invasion, angiogenic and wound repair assays, and pro-inflammatory mediators were quantified by ELISA.

Results: Expression of miR125a-5p was significantly higher in PsA and RA synovial biopsies and/or synovial fibroblasts compared to OA (p<0.05; p<0.05), with highest expresson observed in PsA (p<0.05). Angiogenic growth factor Ang2 induced miR125a-5p in synovial fibroblasts and HMVEC (p<0.05), with no effect observed for TLR ligands or pro-inflammatory cytokines. Silencing of miR by transfection with anti-miR-125a-5p resulted in inhibition of cell invasion, angiogenic tube formation and IL-6 expression. This is consistent with in silico analysis where prediction algorithms identified members of the IL-6 signalling pathway (IL-6R, gp130) as potential targets of miR-125a-5p. 

Conclusion:  Our data provides evidence that miR125a-5p is significantly increased in the inflammed joint, particularly in PsA.  High miR125a-5p expression in PsA and regulation by key angiogenic factor Ang2, is consistent with a possible role for miR125a-5p in the regulation of angiogenic mechanisms. MiR125a-5p also mediated cell migration, angiogenesis and IL-6 expression, key processes involved in the pathogenesis of PsA and RA. In conclusion, miR-125a-5p may be an important regulator of pathogenic mechanisms in inflammatory arthritis and may represent a potential novel target for future therapeutic strategies.


Disclosure: M. Connolly, None; S. Wade, None; D. J. Veale, None; U. Fearon, None.

To cite this abstract in AMA style:

Connolly M, Wade S, Veale DJ, Fearon U. MiR125a-5p Mediates Angiogenic Mechanisms in Inflammatory Arthritis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/mir125a-5p-mediates-angiogenic-mechanisms-in-inflammatory-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mir125a-5p-mediates-angiogenic-mechanisms-in-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology